Free for academic non-profit institutions. Other users need a Commercial license
This gene encodes a CXC chemokine receptor specific for stromal cell-derived factor-1. The protein has 7 transmembrane regions and is located on the cell surface. It acts with the CD4 protein to support HIV entry into cells and is also highly expressed in breast cancer cells. Mutations in this gene have been associated with WHIM (warts, hypogammaglobulinemia, infections, and myelokathexis) syndrome. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]
CXCR4 (C-X-C Motif Chemokine Receptor 4) is a Protein Coding gene. Diseases associated with CXCR4 include Whim Syndrome and Macroglobulinemia. Among its related pathways are Signaling by GPCR and Peptide ligand-binding receptors. Gene Ontology (GO) annotations related to this gene include G protein-coupled receptor activity and ubiquitin protein ligase binding. An important paralog of this gene is CXCR2.
Chemokine receptors are 7-transmembrane G protein-coupled receptors that are activated by the binding of one or more chemokines. Chemokines are a family of chemoattractant molecules with more than 50 having been identified to date. They are categorized according to the number and spacing of conserved cysteines into four main groups: CXC, CC, CX3C and C.
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0001618 | virus receptor activity | IEA | -- |
GO:0003779 | actin binding | IDA | 12421915 |
GO:0004930 | G protein-coupled receptor activity | TAS | 8276799 |
GO:0004950 | chemokine receptor activity | IEA | -- |
GO:0005515 | protein binding | IPI | 10644702 |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0005634 | nucleus | IEA | -- |
GO:0005737 | cytoplasm | TAS | 10415069 |
GO:0005764 | colocalizes_with lysosome | IEA,IDA | 24790097 |
GO:0005768 | endosome | IEA | -- |
GO:0005769 | colocalizes_with early endosome | IEA,IDA | 24790097 |
SuperPathway | Contained pathways | ||
---|---|---|---|
1 | HIV Life Cycle |
.91
.64
|
.45
|
2 | Peptide ligand-binding receptors |
.34
|
|
3 | Chemokine Superfamily Pathway: Human/Mouse Ligand-Receptor Interactions | ||
4 | Akt Signaling |
Akt Signaling
.60
p38 Signaling
.60
|
Tec Kinases Signaling
.55
|
5 | EphB-EphrinB Signaling |
EphB-EphrinB Signaling
.58
Ephrin-Eph Signaling
.58
|
Cytoskeleton remodeling Reverse signaling by ephrin B
.33
|
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0000187 | activation of MAPK activity | TAS | 10570282 |
GO:0001666 | response to hypoxia | IEP | 15174142 |
GO:0001764 | neuron migration | IEA | -- |
GO:0002064 | epithelial cell development | IEA | -- |
GO:0002407 | dendritic cell chemotaxis | TAS | 16621978 |
Name | Status | Disease Links | Group | Role | Mechanism of Action | Clinical Trials |
---|---|---|---|---|---|---|
Plerixafor | Approved | Pharma | Agonist, Partial agonist, Antagonist, Target | 0 | ||
Heparin | Approved, Investigational | Pharma | 1141 | |||
Framycetin | Approved | Pharma | Target, antagonist | 0 | ||
Ibalizumab | Approved, Investigational | Pharma | Target, antagonist | 9 | ||
Bevacizumab | Approved, Investigational | Pharma | VEGF antagonist, Therapeutic Antibodies, Vascular endothelial growth factor (VEGF) and VEGF receptor (VEGFR) inhibitors | 2478 |
Name | Synonyms | Role | CAS Number | PubChem IDs | PubMed IDs | |
---|---|---|---|---|---|---|
SDF-1α |
|
Agonist, Full agonist |
|
|||
vMIP-II |
|
Antagonist |
|
|||
ATI 2341 |
|
1337878-62-2 |
|
|
||
VUF 11222 |
|
1414376-84-3 |
|
|
Compound | Action | Cas Number |
---|---|---|
ATI 2341 | CXCR4 allosteric agonist | 1337878-62-2 |
SB 225002 | Potent and selective CXCR2 antagonist | 182498-32-4 |
SB 265610 | Potent CXCR2 antagonist | 211096-49-0 |
VUF 11207 fumarate | Potent ACKR3 (CXCR7) agonist | |
VUF 11222 | High affinity non-peptide CXCR3 agonist | 1414376-84-3 |
Compound | Action | Cas Number |
---|---|---|
AMD 3465 | CXCR4 antagonist,potent and selective | 185991-24-6 |
AMD 3465 hexahydrobromide | 185991-07-5 | |
AMD-070 | CXCR4 antagonist,potent and selective | 558447-26-0 |
AMD-070 hydrochloride | CXCR4 antagonist,potent and selective | 880549-30-4 |
CTCE 9908 | 1030384-98-5 | |
FC 131 | 606968-52-9 | |
IT1t dihydrochloride | CXCR4 antagonist, potent | 1092776-63-0 |
Plerixafor (AMD3100) | CXCR4 chemokine receptor antagonist | 110078-46-1 |
Plerixafor 8HCl (AMD3100 8HCl) | CXCR4 antagonist | 155148-31-5 |
SRT3109 | 1204707-71-0 | |
TC 14012 | 368874-34-4 | |
UNBS 5162 | A pan-antagonist of CXCL chemokines | 956590-23-1 |
WZ811 | Competitive CXR4 antagonist,highly potent | 55778-02-4 |
This gene was present in the common ancestor of chordates.
Organism | Taxonomy | Gene | Similarity | Type | Details |
---|---|---|---|---|---|
Chimpanzee (Pan troglodytes) |
Mammalia | CXCR4 30 31 |
|
OneToOne | |
Dog (Canis familiaris) |
Mammalia | CXCR4 30 31 |
|
OneToOne | |
Cow (Bos Taurus) |
Mammalia | CXCR4 30 31 |
|
OneToOne | |
Mouse (Mus musculus) |
Mammalia | Cxcr4 30 17 31 |
|
OneToOne | |
Rat (Rattus norvegicus) |
Mammalia | Cxcr4 30 |
|
||
Oppossum (Monodelphis domestica) |
Mammalia | CXCR4 31 |
|
OneToOne | |
Platypus (Ornithorhynchus anatinus) |
Mammalia | CXCR4 31 |
|
OneToOne | |
Chicken (Gallus gallus) |
Aves | CXCR4 30 31 |
|
OneToOne | |
Lizard (Anolis carolinensis) |
Reptilia | CXCR4 31 |
|
OneToOne | |
Tropical Clawed Frog (Silurana tropicalis) |
Amphibia | cxcr4 30 |
|
||
Str.266 30 |
|
||||
African clawed frog (Xenopus laevis) |
Amphibia | cxcr4-prov 30 |
|
||
Zebrafish (Danio rerio) |
Actinopterygii | cxcr4a 30 31 |
|
OneToMany | |
cxcr4b 31 |
|
OneToMany | |||
Rainbow Trout (Oncorhynchus mykiss) |
Actinopterygii | Omy.11892 30 |
|
SNP ID | Clinical significance and condition | Chr 02 pos | Variation | AA Info | Type |
---|---|---|---|---|---|
835055 | Uncertain Significance: Warts, hypogammaglobulinemia, infections, and myelokathexis | 136,114,970(-) |
CAG/C NM_003467.3(CXCR4):c.954_955CT[1] (p.Ser319fs) |
FRAMESHIFT | |
855157 | Uncertain Significance: Warts, hypogammaglobulinemia, infections, and myelokathexis | 136,115,000(-) |
T/C NM_003467.3(CXCR4):c.928A>G (p.Lys310Glu) |
MISSENSE | |
855700 | Uncertain Significance: Warts, hypogammaglobulinemia, infections, and myelokathexis | 136,114,906(-) |
G/T NM_003467.3(CXCR4):c.1022C>A (p.Ser341Tyr) |
MISSENSE | |
863531 | Uncertain Significance: Warts, hypogammaglobulinemia, infections, and myelokathexis | 136,115,795(-) |
AG/A NM_003467.3(CXCR4):c.132del (p.Tyr45fs) |
FRAMESHIFT | |
941105 | Uncertain Significance: Warts, hypogammaglobulinemia, infections, and myelokathexis | 136,115,909(-) |
A/G NM_003467.3(CXCR4):c.19T>C (p.Tyr7His) |
MISSENSE_VARIANT,FIVE_PRIME_UTR |
Disorder | Aliases | PubMed IDs |
---|---|---|
whim syndrome |
|
|
macroglobulinemia |
|
|
intraocular lymphoma |
|
|
aids dementia complex |
|
|
human immunodeficiency virus infectious disease |
|
|